Invenire Partners, LP Artivion, Inc. Transaction History
Invenire Partners, LP
- $65.3 Million
- Q3 2022
A detailed history of Invenire Partners, LP transactions in Artivion, Inc. stock. As of the latest transaction made, Invenire Partners, LP holds 169,414 shares of AORT stock, worth $7.74 Million. This represents 100.0% of its overall portfolio holdings.
Number of Shares
169,414
Previous 114,414
48.07%
Holding current value
$7.74 Million
Previous $2.16 Million
108450.42%
% of portfolio
100.0%
Previous 3.13%
Shares
3 transactions
Others Institutions Holding AORT
# of Institutions
224Shares Held
39.8MCall Options Held
23.3KPut Options Held
0-
Black Rock Inc. New York, NY6.64MShares$303 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.03MShares$138 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C32.48MShares$114 Million0.13% of portfolio
-
Morgan Stanley New York, NY2.24MShares$102 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY2.02MShares$92.3 Million0.19% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.84B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...